Precholesterol sterols accumulate in lipid rafts of patients with Smith-Lemli-Opitz Syndrome and X-linked dominant Chondrodysplasia punctata

Pediatric and Developmental Pathology

Volumn 11, Issue 2, 2008, Pages 128-132

  Rakheja, Dinesh ^a,b   Boriack, Richard L ^a  

^a CHILDREN S MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Lipid rafts; Postsqualene cholesterol biosynthetic disorders; Smith Lemli Opitz syndrome; X linked dominant chondrodysplasia punctata

Indexed keywords

7 DEHYDROCHOLESTEROL; 8 DEHYDROCHOLESTEROL; CHOLEST 8 ENE 3 BETA OL; CHOLESTEROL DERIVATIVE; LATHOSTEROL; STEROL; 7-DEHYDROCHOLESTEROL; CHOLESTA 5,8 DIEN 3 BETA OL; CHOLESTA-5,8-DIEN-3 BETA-OL; CHOLESTEROL;

ARTICLE; AUTOPSY; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL LIVER LEVEL; CHOLESTEROL SYNTHESIS; CHONDRODYSPLASIA PUNCTATA; CONTROLLED STUDY; FEMALE; FETUS; FETUS DEVELOPMENT; HUMAN; HUMAN TISSUE; LIPID RAFT; LIPID STORAGE; LIVER CELL; LIVER HOMOGENATE; NEWBORN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMITH LEMLI OPITZ SYNDROME; X CHROMOSOME LINKED DISORDER; BIOSYNTHESIS; CELL MEMBRANE; CHEMISTRY; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; GENETICS; LIVER; METABOLISM; PATHOLOGY; SYNDROME;

CHOLESTADIENOLS; CHOLESTEROL; CHONDRODYSPLASIA PUNCTATA; DEHYDROCHOLESTEROLS; FEMALE; GENETIC DISEASES, X-LINKED; HUMANS; INFANT, NEWBORN; LIPID METABOLISM, INBORN ERRORS; LIVER; MEMBRANE MICRODOMAINS; SMITH-LEMLI-OPITZ SYNDROME; SYNDROME;

EID: 44949257353     PISSN: 10935266     EISSN: 16155742     Source Type: Journal    
DOI: 10.2350/06-10-0179.1     Document Type: Article

References (33)

1. Kelley RI, Hennekam RC. The Smith-Lemli-Opitz syndrome. J Med Genet 2000;37:321-335.
2. Ryan AK, Bartlett K, Clayton P, et al. Smith-Lemli-Opitz syndrome: a variable clinical and biochemical phenotype. J Med Genet 1998;35: 558-565.
3. Nowaczyk MJ, Zeesman S, Waye JS, Douketis JD. Incidence of Smith-Lemli-Opitz syndrome in Canada: results of three-year population surveillance. J Pediatr 2004;145:530-535.
4. Bzduch y Behulova D, Skodova J. Incidence of Smith-Lemli-Opitz syndrome in Slovakia. Am J Med Genet 2000;90:260.
5. Clayton P, Mills K, Keeling J, FitzPatrick D. Desmosterolosis: a new inborn error of cholesterol biosynthesis. Lancet 1996;348:404.
6. Waterham HR, Koster J, Mooyer P, et al. Autosomal recessive HEM/ Greenberg skeletal dysplasia is caused by 3 beta-hydroxysterol delta 14-reductase deficiency due to mutations in the lamin B receptor gene. Am J Hum Genet 2003;72:1013-1017.
7. Kelley RI, Wilcox WG, Smith M, Kratz LE, Moser A, Rimoin DS. Abnormal sterol metabolism in patients with Conradi-Hunermann-Happle syndrome and sporadic lethal chondrodysplasia punctata. Am J Med Genet 1999;83:213-219.
8. Konig A, Happle R, Bornholdt D, Engel H, Grzeschik KH. Mutations in the NSDHL gene, encoding a 3beta-hydroxysteroid dehydrogenase, cause CHILD syndrome. Am J Med Genet 2000;90:339-346.
9. Brunetti-Pierri N, Corso G, Rossi M, et al. Lathosterolosis, a novel multiple-malformation/mental retardation syndrome due to deficiency of 3beta-hydroxysteroid-delta5-desaturase. Am J Hum Genet 2002;71:952-958.
10. Kelley RI, Kratz LE, Glaser RL, Netzloff ML, Wolf LM, Jabs EW. Abnormal sterol metabolism in a patient with Antley-Bixler syndrome and ambiguous genitalia. Am J Med Genet 2002;110:95-102.
11. Rakheja D, Rogers BB, Bennett MJ. Cholesterol biosynthetic disorders: a review. In: Kramer MA, ed. Focus on Cholesterol Research. Hauppauge, NY: Nova Publications; 2006:21-48.
12. Kelley RI, Herman GE. Inborn errors of sterol biosynthesis. Annu Rev Genomics Hum Genet 2001;2:299-341.
13. Porter JA, Young KE, Beachy PA. Cholesterol modification of hedgehog signaling proteins in animal development. Science 1996;274:255-259.
14. Simons K, Ikonen E. Functional rafts in cell membranes. Nature 1997;387:569-572.
15. Keller RK, Arnold TP, Fliesler SJ. Formation of 7-dehydrocholesterol- containing membrane rafts in vitro and in vivo, with relevance to the Smith-Lemli-Opitz syndrome. J Lipid Res 2004;45:347-355.
16. Rakheja D, Boriack R, Narayan SB, Bennett MJ. Lymphoblasts from patients with Smith-Lemli-Opitz syndrome, when cultured in cholesterol-free medium, incorporate 7-dehydrocholesterol in membrane lipid rafts. Mol Genet Metab 2005;84:234.
17. Kelley RI. Diagnosis of Smith-Lemli-Opitz syndrome by gas chromatography/mass spectrometry of 7-dehydrocholesterol in plasma, amniotic fluid and cultured skin fibroblasts. Clin Chim Acta 1995;236:45-58.
18. Rakheja D, Read CP, Hull D, Boriack RL, Timmons CF. A severely affected female infant with X-linked dominant chondrodysplasia punctata: a case report and a brief review of the literature. Pediatr Dev Pathol 2007;10:142-148.
19. Rakheja D, Narayan SB, Pastor JV, Bennett MJ. CLN3P, the Batten disease protein, localizes to membrane lipid rafts (detergent-resistant membranes). Biochem Biophys Res Commun 2004;317:988-991.
20. Cooper MK, Porter JA, Young KE, Beachy PA. Teratogen-mediated inhibition of target tissue response to Shh signaling. Science 1998;280:1603-1607.
21. Cooper MK, Wassif CA, Krakowiak PA, et al. A defective response to Hedgehog signaling in disorders of cholesterol biosynthesis. Nat Genet 2003;33:508-513.
22. Engelking LJ, Evers BM, Richardson JA, Goldstein JL, Brown MS, Liang G. Severe facial clefting in Insig-deficient mouse embryos caused by sterol accumulation and reversed by lovastatin. J Clin Invest 2006;116:2356-2365.
23. Koide T, Hayata T, Cho KW. Negative regulation of Hedgehog signaling by the cholesterogenic enzyme 7-dehydrocholesterol reductase. Development 2006;133:2395-2405.
24. Simons K, Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 2000;1:31-39.
25. Garcia A, Cayla X, Fleischer A, et al. Rafts: a simple way to control apoptosis by subcellular redistribution. Biochimie 2003;85:727-731.
26. Harris TJ, Siu CH. Reciprocal raft-receptor interactions and the assembly of adhesion complexes. Bioessays 2002;24:996-1003.
27. Ikonen E. Roles of lipid rafts in membrane transport. Curr Opin Cell Biol 2001;13:470-477.
28. Tsui-Pierchala BA, Encinas M, Milbrandt J, Johnson EM Jr. Lipid rafts in neuronal signaling and function. Trends Neurosci 2002;25:412-417.
29. Laloi M, Perret AM, Chatre L, et al. Insights into the role of specific lipids in the formation and delivery of lipid microdomains to the plasma membrane of plant cells. Plant Physiol 2007;143:461-472.
30. Megha, Bakht O, London E. Cholesterol precursors stabilize ordinary and ceramide-rich ordered lipid domains (lipid rafts) to different degrees: implications for the Bloch hypothesis and sterol biosynthesis disorders. J Biol Chem 2006;281:21903-21913.
31. Kovarova M, Wassif CA, Odom S, Liao K, Porter FD, Rivera J. Cholesterol deficiency in a mouse model of Smith-Lemli-Opitz syndrome reveals increased mast cell responsiveness. J Exp Med 2006;203:1161-1171.
32. Tulenko TN, Boeze-Battaglia K, Mason RP, et al. A membrane defect in the pathogenesis of the Smith-Lemli-Opitz syndrome. J Lipid Res 2006;47:134-143.
33. Rakheja D, Boriack RL, Rogers BB. Altered signal protein expression in Smith-Lemli-Opitz syndrome lymphoblasts grown in cholesterol-free medium. Pediatr Dev Pathol 2006;9:397.